These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 32622139)

  • 1. Is the first-line treatment of keratoacanthomas surgical excision or injection of intralesional chemotherapy?
    Hoegler KM; Schleichert RA
    J Am Acad Dermatol; 2020 Nov; 83(5):1542-1543. PubMed ID: 32622139
    [No Abstract]   [Full Text] [Related]  

  • 2. Multiple keratoacanthomas occurring in surgical margins and de novo treated with intralesional methotrexate.
    Veerula VL; Ezra N; Aouthmany M; Graham TA; Wolverton SE; Somani AK
    Cutis; 2016 Dec; 98(6):E12-E15. PubMed ID: 28099546
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intralesional therapy for the treatment of keratoacanthoma.
    Kiss N; Avci P; Bánvölgyi A; Lőrincz K; Szakonyi J; Gyöngyösi N; Fésűs L; Lee G; Wikonkál N
    Dermatol Ther; 2019 May; 32(3):e12872. PubMed ID: 30866135
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of Keratoacanthoma: 157 Tumors Treated With Surgery or Intralesional Methotrexate.
    Moss M; Weber E; Hoverson K; Montemarano AD
    Dermatol Surg; 2019 Jul; 45(7):877-883. PubMed ID: 30608293
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Intralesional methotrexate injection: an effective time and cost saving therapy alternative in keratoacanthomas that are difficult to treat surgically].
    Remling R; Mempel M; Schnopp N; Abeck D; Ring J
    Hautarzt; 2000 Aug; 51(8):612-4. PubMed ID: 10997318
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Treatment of keratoacanthoma with intralesional methotrexate injections].
    Richard MA; Gachon J; Choux R; Laurans R; Folchetti G; Grob JJ
    Ann Dermatol Venereol; 2000 Dec; 127(12):1097. PubMed ID: 11173689
    [No Abstract]   [Full Text] [Related]  

  • 7. Successful non-operative treatment of eruptive keratoacanthomas refractory to excision.
    Seger EW; Tarantino IS; Neill BC; Wang T
    Dermatol Online J; 2020 Mar; 26(3):. PubMed ID: 32609455
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intralesional methotrexate in keratoacanthoma of the nose.
    Hurst LN; Gan BS
    Br J Plast Surg; 1995 Jun; 48(4):243-6. PubMed ID: 7640859
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intralesional methotrexate in solitary keratoacanthoma.
    Cuesta-Romero C; de Grado-Peña J
    Arch Dermatol; 1998 Apr; 134(4):513-4. PubMed ID: 9580539
    [No Abstract]   [Full Text] [Related]  

  • 10. Treatment of keratoacanthomas with intralesional methotrexate.
    Melton JL; Nelson BR; Stough DB; Brown MD; Swanson NA; Johnson TM
    J Am Acad Dermatol; 1991 Dec; 25(6 Pt 1):1017-23. PubMed ID: 1810980
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of giant keratoacanthoma with intralesional 5-fluorouracil.
    Leonard AL; Hanke CW
    J Drugs Dermatol; 2006 May; 5(5):454-6. PubMed ID: 16703783
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intralesional corticosteroid treatment of multiple eruptive keratoacanthomas: case report and review of a controversial therapy.
    Sanders S; Busam KJ; Halpern AC; Nehal KS
    Dermatol Surg; 2002 Oct; 28(10):954-8. PubMed ID: 12410683
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Topical and intralesional treatment of nonmelanoma skin cancer: efficacy and cost comparisons.
    Chitwood K; Etzkorn J; Cohen G
    Dermatol Surg; 2013 Sep; 39(9):1306-16. PubMed ID: 23915332
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intralesional 5-fluorouracil for keratoacanthoma of the eyelid.
    Bergin DJ; Lapins NA; Deffer TA
    Ophthalmic Plast Reconstr Surg; 1986; 2(4):201-4. PubMed ID: 3154563
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Solitary Large Keratoacanthomas of the Head and Neck: An Observational Study.
    Rossi AM; Park B; Qi B; Lee EH; Busam KJ; Nehal KS
    Dermatol Surg; 2017 Jun; 43(6):810-816. PubMed ID: 28296794
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Intralesional infusion of methotrexate as neoadjuvant therapy improves the cosmetic and functional results of surgery to treat keratoacanthoma: results of a randomized trial].
    Martorell-Calatayud A; Requena C; Nagore E; Sanmartín O; Serra-Guillén C; Botella-Estrada R; Sanz-Motilva V; Llombart B; Alcañiz-Moscardo A; Guillén-Barona C
    Actas Dermosifiliogr; 2011 Oct; 102(8):605-15. PubMed ID: 21742301
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of Solitary Keratoacanthoma of the Nose With Intralesional Methotrexate and Review of the Literature.
    Doerfler L; Hanke CW
    J Drugs Dermatol; 2019 Jul; 18(7):693-696. PubMed ID: 31334929
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intralesional methotrexate for keratoacanthomas: A retrospective cohort study.
    Smith C; Srivastava D; Nijhawan RI
    J Am Acad Dermatol; 2020 Sep; 83(3):904-905. PubMed ID: 32268170
    [No Abstract]   [Full Text] [Related]  

  • 19. Large keratoacanthomas in difficult locations treated with intralesional 5-fluorouracil.
    Parker CM; Hanke CW
    J Am Acad Dermatol; 1986 May; 14(5 Pt 1):770-7. PubMed ID: 3711381
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Eruptive keratoacanthomas as a complication of fractionated CO2 laser resurfacing and combination therapy with imiquimod and intralesional methotrexate.
    Panther D; Nino T; Macknet KD; Macknet C
    Dermatol Surg; 2015 Jan; 41(1):172-5. PubMed ID: 25533164
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.